ArticleFrontiers in oncology2022

Anlotinib for the Treatment of Multiple Recurrent Lumbar and Sacral Cord Hemangioblastomas: A Case Report.

Nan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.